Budget Impact Analysis of Crizotinib as Treatment of Anaplastic Lymphoma Kinase (ALK) Positive Advanced Nsclc in Panama
May 1, 2014, 00:00 AM
10.1016/j.jval.2014.03.439
https://www.valueinhealthjournal.com/article/S1098-3015(14)00490-2/fulltext
Section Title :
Cancer
Section Order :
1485
First Page :
A75
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00490-2&doi=10.1016/j.jval.2014.03.439